Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus: A study of 177 patients

Archives of Dermatology

Volumn 132, Issue 12, 1996, Pages 1448-1452

  Cribier, Bernard ^a   Rey, David ^a   Uhl, Georges ^a   Le Coz, Christophe ^a   Hirth, Christine ^a   Libbrecht, Eric ^a   Vetter, Denis ^a   Lang, J Marie ^a   Stoll Keller, Françoise ^a   Grosshans, Edouard ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; PORPHYRIN;

ADULT; ARTICLE; DNA DETERMINATION; ENZYME ACTIVITY; FAMILIAL DISEASE; FEMALE; HEPATITIS C VIRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER METABOLISM; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PORPHYRIA CUTANEA TARDA; PORPHYRIN METABOLISM; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 12644283534     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.132.12.1448     Document Type: Article

References (20)

1. Elder GH. Recent advances in the identification of enzyme deficiencies in the porphyrias. Br J Dermatol. 1983;108:729-734.
2. Blauvelt A, Harris HR, Hogan DJ, et al. Porphyria cutanea tarda and human immunodeficiency virus infection, Int J Dermatol. 1992;31:474-479.
3. Conlan MG, Hoots WK. Porphyria cutanea tarda in association with human immuno-deficiency virus infection in an hemophiliac. J Am Acad Dermatol. 1992;26:857-859.
4. El Sayed F, Viraben R, Bazex J, Gorguet B. Porphyrie cutanée tardive et infection à VIH-1: deux nouveaux cas. Ann Dermatol Venereol. 1993;120:455-458.
5. MacAlister F, McLean K, Hamilton PG, Houston S. Human immunodeficiency virus infection and porphyria cutanea tarda: coexistence of risk factors or causative association? Clin Infect Dis. 1995;20:348-351.
6. Fargion S, Piperno A, Cappellini MD, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology. 1992;16:1322-1326.
7. Herrero C, Vicente A, Bruguera M, et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet. 1993;341:788-789.
8. D'Alessandro Gandolfo L, Biolcalti G, Griso D, et al. Frequency of viral hepatitis markers in porphyria cutanea tarda, Eur J Dermatol. 1993;3:180-182.
9. Navas S, Bosch O, Castillo I, Marriott E, Carreno V. Porphyria cutanea tarda and hepatitis C and B viruses infection: a retrospective study. Hepatology. 1995; 21:279-284.
10. Stölzel U, Köstler E, Koszka C, et al. Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology. 1995;21:1500-1503.
11. Cribier B, Petiau P, Keller F, Schmitt C, Heid E, Grosshans E. Porphyria cutanea tarda and hepatitis C virus infection: a clinical and virological study. Arch Dermatol. 1995;131:801-804.
12. Lim CK, Peters TJ. Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias. Clin Chim Acta. 1984; 139:55-63.
13. Fuchs D, Artner-Dworzak E, Hausen A, et al. Urinary excretion of porphyrins is increased in patients with HIV-1 infection. AIDS. 1990;4:341-344.
14. O'Connor W, Murphy GM, Darby C, et al. Abnormal porphyrin metabolism in HIV infection. Br J Dermatol. 1994;131(suppl):37-38.
15. Nomura N, Fotiades J, Lim HW, et al. Serum porphyrin In patients with HIV infection. J Invest Dermatol. 1995;104:654. Abstract.
16. O'Reilly F, Darby C, O'Moore R, Fielding JF, Murphy GM. Porphyrin metabolism in hepatitis C infection secondary to anti-D immunoglobulin. Photodermatol Photoimmunol Photomed. 1995;11:40. Abstract.
17. Localio SA, Schwartz MS, Gannori CF. The urinary/fecal coproporphyrin ratio in liver disaese. J Clin Invest. 1941;20:7-11.
18. Aziz MA, Shwartz S, Watson CJ. Studies of coproporphyrin: reinvestigation of the isomer distribution in jaundice and liver diseases. J Lab Clin Med. 1964; 63:596-604.
19. Ben-Ezzer J, Rimington C, Shani M, Seligsohn U, Sheba C, Szeinberg A. Abnormal excretion of the isomers of urinary coproporphyrin by patients with Dubin-Johnson syndrome in Israël. Clin Sci. 1971;40:17-30.
20. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko G, Lee C. The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol. 1994;87:555-561.